Tuesday 13 October 2026
Export CNC’s income statement to Excel — free account
Centene Corporation
CNC Healthcare Healthcare Plans
Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.92%, EPS grew 533.3%, free cash flow grew 116.6% and total debt fell 8.37%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
68.86
1.84
+2.75%
Follow CNC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.09 | 0.10 | 0.08 | 0.16 | |
P/FCF ratio |
5.22 | 4.70 | 2.27 | 3.54 | |
P/Operating CF |
12.92 | 46.43 | 3.69 | 8.83 | |
P/B ratio |
0.83 | 1.01 | 0.75 | 1.40 | |
Price to Tangible BV |
3.27 | 4.35 | 2.56 | 4.17 | |
EV/Sales |
0.09 | 0.09 | 0.04 | 0.10 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
3.91 | 3.41 | 1.10 | 2.13 | |
EV/FCF |
4.73 | 4.02 | 1.23 | 2.32 | |
Quick Ratio |
1.04 | 1.05 | 1.08 | 1.11 | |
Current Ratio |
1.08 | 1.10 | 1.12 | 1.15 | |
Net Debt/EBITDA |
0.25 | 2.06 | (3.41) | (7.31) | |
Debt/Assets |
21.42% | 22.67% | 20.17% | 19.40% | |
Debt/Equity |
0.84 | 0.87 | 0.76 | 0.71 | |
Asset Turnover |
2.26 | 2.45 | 2.36 | 2.40 | |
Operating CF/Net income |
(0.20) | (0.40) | 2.83 | 3.29 | |
Capex/Depreciation |
(0.67) | (0.65) | (0.67) | (0.58) | |
Interest Coverage |
(40.91) | (10.39) | 11.35 | 7.83 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.33% | 6.78% | 6.80% | 5.79% | |
Intangible Assets out of Total Assets |
0.19 | 0.20 | 0.19 | 0.18 | |
Share Based Compensation of Revenue |
0.10% | 0.12% | 0.13% | 0.11% | |
Graham Net Nets |
(0.97) | (0.81) | (0.91) | (0.43) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(30.27%) | (33.07%) | (40.07%) | (16.20%) | |
Free Cash Flow Yield |
19.15% | 21.29% | 44.15% | 28.24% | |
Revenue per Share |
101.17 | 100.84 | 101.50 | 108.50 | |
Operating CF per Share |
2.76 | 0.89 | 8.87 | 7.27 | |
Capex per Share |
(0.43) | (0.43) | (0.41) | (0.35) | |
Free Cash Flow per Share |
2.33 | 0.45 | 8.47 | 6.92 | |
Cash per Share |
39.17 | 41.21 | 48.25 | 54.79 | |
Shareholders Equity per Share |
42.82 | 40.63 | 43.70 | 45.83 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
42.82 | 40.63 | 43.70 | 45.83 | |
Free Cash Flow |
1,145.00 | 224.00 | 4,166.00 | 3,416.00 | |
Working Capital |
3,432.00 | 3,652.00 | 4,944.00 | 5,926.00 | |
Capital Expenditures |
(211.00) | (213.00) | (200.00) | (174.00) | |
Net Current Asset Value |
(16,993.00) | (16,344.00) | (14,684.00) | (13,693.00) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
20,695.00 | 18,909.00 | 20,931.00 | 19,814.00 | |
Average Payables |
15,106.50 | 13,485.00 | 15,390.00 | 15,742.50 | |
Average Assets |
82,219.00 | 79,596.00 | 84,109.50 | 84,703.50 | |
Average Common Equity |
24,214.00 | 23,266.50 | 24,754.50 | 25,063.00 |
Columns are period end dates